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Abstract
Background: Documenting the indication on prescriptions and dispensed medicines labels is not standard practice
in Australia. However, previous studies that have focused on the content and design of dispensed medicines labels,
have suggested including the indication as a safety measure. The aim of this study was to investigate the perspectives
of Australian consumers, pharmacists and prescribers on documenting the indication on prescriptions and dispensed
medicines labels.
Methods: Semi-structured interviews were conducted and mock-up of dispensed medicines labels were designed for
participants. Consumers (n = 19) and pharmacists (n = 7) were recruited by convenience sample at community
pharmacies in Sydney (Australia) and prescribers (n = 8), including two medical students, were recruited through
snowballing.
Results: Thirty-four participants were interviewed. Most participants agreed that documenting the indication
would be beneficial especially for patients who are forgetful or take multiple medications. Participants also
believed it would improve consumers’ medication understanding and adherence. Prescribers and pharmacists
believed it could help reduce prescribing and dispensing errors by matching the drug/dosage to the correct
indication. Prescribers refrained from documenting the indication to protect patients’ privacy; however, most
patients did not consider documenting the indication as a breach of privacy. Prescribers raised concerns about the
extra time to include indications on prescriptions and best language to document indications, using plain language
as opposed to medical terminology.
Conclusions: All interviewed stakeholders identified numerous benefits of documenting the indication on
prescriptions and dispensed medicines labels. Whether these potential benefits can be realized remains unknown and
addressing prescribers’ concern regarding the time involved in documenting the indication on prescriptions remains a
challenge for vendors of electronic medication management systems.
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Background
The guidelines for labelling dispensed medicines in
Australia requires information such as the directions for
use, the dose form and the quantity supplied to be
clearly visible on the label. [1] However, neither the pre-
scription nor the dispensed medicine label requires the
documentation of the indication or purpose of the medi-
cation. The Australian National Inpatient Medication
Chart (NIMC) is a paper and electronic chart that
health-care professionals use in public hospitals to docu-
ment information (e.g. route, dose) on the medications
of an inpatient [2]. The NIMC includes a section where
the indication of a medication can be documented, but
compliance is low (8.9%) [3]. The dispensed medicine
label, along with a Consumer Medicine Information
(CMI) leaflet, is often the final mode of communication
between the prescriber, pharmacist and consumer.
Ensuring the dispensed medicine label contains adequate
information for the consumer to refer to for the medi-
cine’s appropriate use is thus crucial. Unfortunately,
consumers and pharmacists may be unsure about the
specific indication for a dispensed medication [4].
Including the indication is common practice in some
European countries [5]. In Sweden for example, the indi-
cation must be written in lay Swedish terms on a dis-
pensed medicine label so consumers can understand
what the medication is to be used for [5]. A retrospect-
ive study of prescription errors in Swedish community
pharmacies found that having the indication docu-
mented on the prescription helped pharmacists identify
and rectify prescription errors [6].
Previous qualitative studies, which have focused on the
content and design of the dispensed medicine label, have
found that 28% to 91% of patients were in favour of doc-
umenting the indication on the dispensed medicine label
[7–13]. Additionally, two literature reviews on best label
practice, comprising the results of 135 individual studies,
found that consumers want the indication documented
on the dispensed medicines labels to better understand/
remember what the medications are used for [14, 15].
Furthermore, a prospective descriptive study conducted
in Australia over 20 years ago explored the views of pre-
scribers, pharmacists and consumers on new prescrip-
tion layouts [16]. The proposed prescription layout at
the time included a section in which the general practi-
tioner (GP) could document the indication of the
medication [16]. In the study, 35% (n = 1222) of the new
prescription layouts had the indication documented as
part of the written directions [16]. Even though it has
been known for many years that consumers, pharmacists
and GPs feel that documenting the indication on the
prescription and the dispensed medicine label could lead
to better medication management and patient care [16],
this is still not common practice in Australia.
The aim of this study was to investigate current per-
spectives of various Australian stakeholders, including
consumers, pharmacists and prescribers, regarding doc-
umenting the indication on prescriptions and dispensed
medicines labels.
Methods
This qualitative study was approved by the University of
Sydney’s Human Research Ethics Committee (ref: 2016/
443). Three slightly different semi-structured interview
guides were developed for interviews with consumers,
pharmacists and prescribers respectively (Additional file 1).
The questions were constructed to gain insight into medi-
cation use (taking/not taking medications) and explore par-
ticipants’ views on documenting the indication on the
dispensed medicine label, how that information should be
worded, and its potential effect on medication errors and
patient safety. The interviewer (MG) conducted practice
interviews with pharmacy students and members of the re-
search team, before data collection begun. A number of
mock-up dispensed medicines labels with different wording
were created and presented to participants for consider-
ation during the interviews (Additional file 2). This was
done to ensure all participants understood by documenting
the indication on dispensing labels, and to explore the pre-
ferred wording.
Study participants and data collection
A convenience sample of consumers and pharmacists
were recruited in community pharmacies whereas pre-
scribers (general practitioners and hospital doctors) were
recruited using snowball sampling from general practice
and the public hospital setting. Eligible participants
(taking, picking up, prescribing or dispensing medica-
tions and proficient in English) were informed verbally
by the interviewer and provided a written information
sheet outlining the purpose of study (to explore Australians’
views regarding documenting the indication on prescrip-
tions and dispensing labels). Participants were interviewed
once by one female interviewer (MG) as soon as written
consent had been obtained. The interviews were conducted
in quiet settings of the interviewees’ workplaces and no
other person was present but the interviewer and inter-
viewee. Interviews with consumers took place in a quiet
area of the pharmacy. Only the interviewer and interviewee
were present during the interview. Interviews were audio-
recorded and transcribed verbatim. No field notes were
taken when the interviews were audio-recorded. If the par-
ticipant did not consent to audio-recording, the partici-
pants’ answers were handwritten during the interview. The
audio-recorded interviews took an average of seven
minutes and 43 s. Data collection took place in August –
September 2015. Only one consumer who was approached
declined to participate.
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Participants were asked to complete a brief demo-
graphic questionnaire before the interview. The partici-
pant demographic form included information on the
participants’ gender; age; number of prescription medica-
tions; whether they were a consumer, prescriber or a
pharmacist and if the latter, their setting of practice (e.g.
hospital, community, public sector, private sector).
Data analysis
Transcribed interviews were imported to NVivo 11
(NVivo qualitative data analysis software; QRS Inter-
national Pty, V11). Initial data coding was undertaken in
parallel with data collection. Data collection ceased
when no new themes were being identified, indicating
that data saturation had been achieved [17].
Applying the framework method [18], the data were
coded using NVivo. Codes with similar meaning were
grouped together into different categories, and a total of
four themes were identified on documenting the indica-
tion on prescriptions and dispensed medicines labels;
the potential benefits, the potential limitations, describ-
ing the indication on the dispensed medicine label and
the safety improvements.
Results
A total of 34 participants were interviewed and their
demographic details are shown in Table 1. All but two
interviews were audio-recorded. At least one medication
was taken by 65% of the participants. A summary of key
points for each theme is shown in Table 2.
Potential benefits of documenting the indication on
dispensed medicines labels
Most of the consumers reported that documenting the
indication on the dispensed medicine label would help
them identify what their medications were for. These
participants perceived having the indication on dis-
pensed medicines labels would make managing medica-
tion less confusing, especially for those on multiple
medications and for people who are forgetful. The idea
of documenting the indication on the dispensed medi-
cines label was perceived as particularly important when
starting a new medication or when an alternative brand
was dispensed as consumers reported being more con-
fused in these situations. One consumer (#15) reported:
“…you have more information, it can only help”. Another
consumer (#14) agreed and added: “I look at it as just
another positive [piece of] information they’re getting…”.
Most consumers not only perceived having the indica-
tion on the dispensed medicines label as beneficial for
themselves, but also for their partners and other care-
givers. For example, individuals who collect medications
on behalf of someone else thought it would be useful for
everyone involved if the indication was documented on
the dispensed medicine label. Consumers also felt it was
beneficial to document the indication on the dispensed
medicine label for topically applied medicines (e.g.
creams) as well as eye and ear drops because these prod-
ucts can be used for different health conditions by differ-
ent consumers.
However, not all consumers felt it was necessary to
document the indication on the dispensed medicine
label. In fact, some consumers felt that if healthcare pro-
fessionals required the indication to be documented,
Table 1 Participant demographics
Number of
participants (%)
Gender Female 27 (79.4)









Occupation Consumer 19 (55.9)
Pharmacist 7 (20.6)
Prescriber 6 (17.6)





Private sector 2 (13.3)
Table 2 Key theme points identified
Theme Key Points
Potential benefits • Reminder to take medications
• Help when picking up medications
on behalf of someone else
• Useful with non-tablet medications (e.g. creams)
• May encourage health checks
• Medication reconciliation
• Helps with the management of a patient in
emergency situations
• Helps when medication has multiple indications
Potential limitations • Privacy concerns
• Overcrowding of the label




• Medical terminology may make consumer take
condition more seriously
• Treatment specificity preferred with anti-infectives
Potential Safety
Benefits
• May reduce confusion with generic brand
substitutions
• Helps health-care professional match dose to
indication
• May reduce look-alike sound-alike errors
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they would be worried. As one consumer (#19) stated, “I
think if my doctor needed to have that I would be wor-
ried, because they should know what things are for!”
Some consumers were indifferent to the notion of docu-
menting the indication, but most were in agreement that
it would be “good”.
Most of the pharmacists in the study stated that docu-
menting the indication on the dispensed medicine label
would be beneficial as consumers would be “clued in to
what conditions they have,” (Pharmacist #6), “it helps
patients just taking control over their own medications,
knowing what they’re taking and why, having that
information is power to them,” (Pharmacist #7) and “the
consumer themselves are more hungry for information
these days” (Pharmacist #7). Some pharmacists stated
that it would be helpful to document the indication on
the dispensed medicine label for older patients who are
prescribed many different medications. As one pharma-
cist (#5) stated: “…possibly for those people that we assess
who don’t fully understand or maybe those patients who
are a bit…and I’ll generalize…a little bit older…to help
for their understanding of their therapy treatment…”
Additionally, pharmacists reported it would be beneficial
to document the indication on the prescription when
the medication has multiple indications or when the
medication is being used “off-label”.
Most of the pharmacists also identified having the
indication on dispensed medicines labels as some-
thing positive when consumers had old repeat (refill)
prescriptions for an antibiotic and were deciding to
fill it in when they were not feeling well. “…often
they would bring a script from, you know, six months
ago, or something, for an antibiotic, which they can’t
remember what it was prescribed for…and then
they’ll say, ‘I’ve got this terrible cough, will this work
for me?’, I think it would help to have an indication.”
(Pharmacist #3) However, other pharmacists viewed
counselling as more important and believed it suffi-
cient to educate the patient on the indications of
their medications.
Prescribers reported that documenting the indica-
tion would be worthwhile as it would assist in sus-
taining continuity of care for patients who were
being treated by multiple healthcare professionals.
Prescribers practicing in hospitals reported that if
the indication was documented on the dispensed
medicine label, it would help with medication recon-
ciliation. Currently, prescribers make “educated
guesses” (prescriber #1) or ask the patient to explain
what their medications are for. Additionally, one
prescriber (prescriber #1) reported that knowing the
indication, for example whether metoprolol was be-
ing used for heart failure or hypertension, would im-
pact on the management of patients.
Possible impact on medication adherence
Most of the participants reported that documenting the
indication would make them “more inclined to” (con-
sumer #14) take their medications thus improve their
medication adherence. Healthcare professionals, espe-
cially prescribers, tended to agree. A prescriber said that
conditions such as “…blood pressure or diabetes, it’s
more based on…blood test results or blood test readings
that they need to be on the tablets, it’s not how they
feel…,” (prescriber #6); and so, documenting the indica-
tion would help remind them of their condition and en-
courage them to continue to take the medication as
prescribed. One medical student stated that perhaps by
documenting the indication of conditions that are
asymptomatic and require tests, such as hypertension,
would encourage consumers to have regular check-ups.
In addition, one consumer (consumer #11) believed that
documenting the indication for a cholesterol-lowering
medication can encourage individuals to maintain their
cholesterol levels “within acceptable limits”.
Potential limitations of documenting the indication on
dispensed medicines labels
When asked what could be negative about documenting
the indication on the dispensed medicine label, patients
felt that the dispensed medicine label is already over-
crowded and contains too much information. One
consumer believed it would be good to document the in-
dication “…as long as it doesn’t get lost in all the small
print, because a lot of people aren’t going to read it
anyway,” (consumer #11). Not reading the label, hence
missing important information, was another potential
limitation identified by consumers. As one consumer
stated, “Yeah, but when you got ten or a dozen of these,
you’re not continually reading all labels…,” (consumer
#16). Consumers also reported that the small font on
the dispensed medicine label would discourage them
from referring to it.
Prescribers expressed concerns about the time it
would take to document the indication on the prescrip-
tion and how challenging it would be to find that time
in an already time pressure environment. Interestingly,
prescribers stated that documenting the indication for
medications that had, what they perceived to be, an
obvious indication, such as a statin for hypercholester-
olemia, would be a nuisance and unnecessary. Pre-
scribers, including the medical students, thought it
would also be a challenge to clarify, or rather narrow
down, the exact indication for a medication that can
be used for multiple indications.
Privacy concerns
Privacy was mentioned multiple times by participants
when talking about potential limitations of documenting
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the indication on dispensed medicine labels. One pre-
scriber referred to this practice as a possible “breach of
confidentiality” (prescriber #2). Specifically, conditions
such as mental health conditions, sexual dysfunction,
sexually transmitted diseases (e.g. genital herpes), cancer
and HIV were mentioned as particularly problematic.
Healthcare professionals acknowledged this and suggested
strategies whereby patients had to provide consent to hav-
ing the indication documented on prescriptions and dis-
pensed medicines labels.
Interestingly, most of the consumers said they would
be comfortable with having the indication documented
on the dispensed medicine labels even for sensitive con-
ditions because healthcare professionals already know
what medical conditions they have, hence it would not
be a privacy issue. However, some consumers did not
want their family members to know the exact indication
for some of the medications they were taking hence did
not want the indication documented. On the other hand,
other consumers stated that privacy “goes out the door”
when you are living with someone, and thus privacy
would not be an issue when it comes to documenting
the indication. Some participants also reported that dis-
posing the medication box with the indication on the
label could potentially result in a breach of privacy if an
unauthorised person, such as a neighbour, found the
medication box.
Describing the indication on dispensed medicines labels
Almost all participants preferred the mock-up dispensed
medicine label written in plain English without any med-
ical terms or jargon. For example, most patients pre-
ferred “…to lower blood pressure,” as opposed to “…for
hypertension.” Healthcare professionals thought it would
be best to keep it as simple as possible for the consumer.
However, some prescribers believed that by docu-
menting the indication in medical terms, such as
“psoriasis” as opposed to a “skin rash” or “for severe
COPD” instead of “difficulty breathing” would make
the patient take their condition more seriously and
comply better to the medication.
When participants were asked about how specific the
indication should be (e.g. infection or urinary tract infec-
tion), most participants stated that it would be better to
be more specific. However, some consumers stated that
for a short-term course of an anti-infective, documenting
the indication would not be necessary as they would know
what infection they had, hence what the medication was
being used for. Pharmacists on the other hand believed
documenting the specific indication for anti-infectives
would lead to more appropriate use of antibiotics. That is,
if the label clearly stated that the medication was for
“urinary tract infection” rather than “infection” consumers
might be discouraged from inappropriate self-medicating.
Potential safety benefits
Most participants felt that documenting the indication
has a role in preventing medication errors and reducing
or avoiding harm. Participants felt that the indication
could be somewhat of a safety check for healthcare pro-
fessionals and consumers alike. Pharmacists believed
that it may reduce prescribing and dispensing errors of
‘look-alike, sound-alike’ medications. One pharmacist
(#4) gave the example of allopurinol sounding very simi-
lar to haloperidol, which are used for completely differ-
ent conditions. Prescribers reported that errors could be
reduced by matching the correct drug and dosage for
the correct indication. A medical student (#2) stated
that: “…they [the pharmacists] would have an idea of the
dosages for different conditions, like if a patient is on
doxycycline for an acute infection it might be different to
doxycycline for malaria or for…acne…”. Another pre-
scriber (#6) stated: “I have seen that in the past, where
they have been given the wrong dose because that dose is
for a different condition…so if it came up what the indi-
cation was, there’s also double checking the right dose,
yeah. I can see that helping”.
Discussion
This study investigated the perspectives of consumers,
pharmacists and prescribers, on documenting the indica-
tion on the prescription and dispensed medicines labels.
In this study, most participants expressed positive views
about documenting the indication on prescriptions and
dispensed medicines labels.
Despite the potential benefits participants identified
with including the indication, privacy was a concern
raised by all. Similar concerns were raised by partici-
pants in a Dutch study, where consumers did not want
conditions such as sexually transmitted infections, can-
cer or even onychomycosis to be documented on the
dispensed medicine label [8]. Interestingly, even though
consumers discussed privacy concerns in general,
Australian consumers appeared accepting of document-
ing the indication for a sensitive or stigmatized condi-
tion if the medication was for themselves. In our study, it
was mainly prescribers and pharmacists who worried
about consumers’ privacy indicating that healthcare pro-
fessionals’ concern may outweigh consumers’ actual
concern and fears, and that consumers’ privacy can be
maintained by simply asking them whether or not they
want the indication documented on prescriptions and
dispensed medicine labels.
Some pharmacists believed that verbal medication
counselling is more important than documenting the in-
dication on the dispensed medicine label. We are not
suggesting that documenting the indication on dispensed
medicine labels would replace medication counselling,
but can complement verbal counselling thereby providing
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an added safety measure to improve consumer medication
understanding and reduce prescribing and dispensing
errors. In fact, a study in which the indication was docu-
mented on the prescription for pharmacists helped phar-
macists confirm the medication was correct for the
indication provided [19]. Knowing the indication may also
facilitate appropriate medication counselling whereby the
pharmacist can tailor the information and make it more
“patient-centred”. Previous studies have reported that
pharmacists preferred to have the indication on the pre-
scription to avoid having to ask the consumer or guess the
indication [11, 20]. Moreover, in the study by Liddell and
Goldman [16], prescribers and pharmacists believed that
documenting the indication would improve the quality of
information and minimize irrelevant and inappropriate
advice as well as provide consistent advice from all health-
care professionals. Pharmacists also reported in a previous
study that being provided the indication on prescriptions
helped reduce consultation time with the prescriber in
order to clarify or correct prescriptions from 38.7%
(n = 22/57) to 61.5% (n = 8/13); hence decreasing inter-
ruptions for prescribers [19]. Previous research have found
that pharmacists make better clinical decisions if they
know the diagnosis or reason for prescribing [21]. This
holds true for electronic prescriptions as well [19].
Warholak-Juarez et al. studied how additional patient
information given to a pharmacist would affect their
clinical decision making [21] and found that pharmacists
were able to make better clinical decisions when they
had more patient information available to them, such as
the diagnosis/problem (i.e. purpose of the medication)
[21]. The less information pharmacists had about the pa-
tient, the more they realized the assumptions they were
making [21]. Compared to having complete patient in-
formation to incomplete information, pharmacists in the
study by Warholak-Juarez et al. were able to realize the
risk they could have put a patient in when making clin-
ical decisions without complete patient information [21].
This further supports the positive effect of having the
indication documented on a prescription.
The wording of the indication on the prescription and
dispensed medicine label was a source of concern among
the participants in this study. Previous studies have
shown that consumers prefer written information to be
in plain language to help their medication understanding
and management [12, 22, 23]. A previous review also
had healthcare professionals agreeing to keep written in-
formation in plain language [23]. Similarly in our study
consumers favoured simple, plain language; however
some healthcare professionals wanted to use more med-
ical terms. However there is an issue of how the indica-
tion can best be documented—should it be by symptom,
health problem, diagnosis, ICD-10 or SNOMED-CT [4].
A study trial conducted on indication-based prescribing
of antihypertensive medications allowed prescribers use
either free text or common discrete codes of ICD-9 CM
or SNOMED [24]. The study highlighted that the tech-
nology to process free text clinical documentation is
promising but requires optimisation [24]. Agreeing on
the terminology to be used will enable vendors to in-
corporate shortlists of indications and other technical
support in software that will facilitate safe and efficient
documentation of indication when prescribing and dis-
pensing medications.
Another issue that would create problems for pre-
scribers including the indication on prescriptions is that
they do not always know what indication they are treat-
ing. Schiff and colleagues note that there is a “complex-
ity in defining and creating indications” for prescribing
systems as well as the use of empirical treatments with
medications when there is no definite diagnosis [4].
However this need not necessarily mitigate against the
need and value of indications-based prescribing, only for
developing approaches that help overcome these issues.
A previous study on indication-based prescribing sys-
tems has shown that an indication prompts may be able
to improve problem list documentation [24], and by
doing so, perhaps an indication-based prescribing system
could assist prescribers to prescribe more appropriately
in these situations. Another study on indication-based
prescribing for off-label medications was encouraging in
showing that decision support software could be de-
ployed to help recommend on-label alternatives or off-
label alternatives with a higher degree of evidence when
the indication is entered by clinicians [25].
One promising approach to documenting the indica-
tion on prescriptions is to design and implement an
indication-based prescribing system in which the pre-
scriber first select an indication (rather than the drug)
and the prescribing system would help narrow down the
choices of medications to those indicated for that condi-
tion [4]. A smart system would even be able to incorpor-
ate other patient specific information such as medications
previously tried and failed or renal status that might
contraindicate (and thus not include on the list of choices)
a medication. A previous study on indication-based pre-
scribing systems has shown that indication prompts can
potentially intercept wrong charting of medications and
intercept drug name confusion errors [24].
In summary, the findings from this qualitative study
suggest that key stakeholders including consumers,
pharmacists and prescribers in Australia all support the
notion of including the indication on prescriptions and
dispensed medicine labels. Future studies should investi-
gate the impact of documenting the indication on medi-
cation error rates and patient outcomes. These may
include a randomized control trial to measure the effects
of documenting the indication on patient medication
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knowledge, adherence rates and clinical outcomes; a
study using a mystery shopper design to assess pharma-
cists’ ability to detect prescribing errors on prescriptions
with and without the indication; and an evaluation of
different prescribing and dispensing software.
The strengths and weaknesses of this study include a
number of factors. This study comprised 34 participants,
providing ample qualitative data to explore the topic.
Another strength was the inclusion of different stake-
holders. However, most participants were from metro-
politan New South Wales regions of Australia, limiting
the generalisability to other settings. However our find-
ings closely mirrored those of other studies and com-
mentaries on this subject.
Conclusions
This study identified and reinforced a number of poten-
tial benefits to documenting the indication on the
prescription and the dispensed medicine label which
participants felt outweigh any potential limitations. The
main perceived benefits of including the indication were
improved medication management, better understanding
of medications among consumers, improved medication
adherence and a possible reduction in medication errors.
Changing prescribing practices represents a fundamental
change hence the potential workflow and practice bar-
riers, particularly time to document and privacy con-
cerns, need to be addressed to fully realize the potential
of incorporating indications into prescriptions and dis-
pensed medication labels, although there are likely cre-
ative ways these barriers can be effectively overcome.
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